NAV Growth
Growth of each fund's NAV over the selected period, rebased to 0%
-
-
-
1M
3M
6M
1Y
3Y
5Y
Fund Details
Returns
Risk Ratios
Trailing risk-adjusted performance measures
Holding Analysis
Top Holdings
DSP Healthcare Fund - Direct (G)
| Name | Assets |
|---|---|
 Apollo Hospitals En...Equity | 7.89% |
 Ipca Laboratories LtdEquity | 7.49% |
 Cipla LtdEquity | 7.40% |
 Sun Pharmaceutical ...Equity | 7.32% |
 Gland Pharma LtdEquity | 6.61% |
| Sai Life Sciences LtdEquity | 6.17% |
| Globus Medical IncForeign Equity | 5.36% |
| Alkem Laboratories LtdEquity | 4.73% |
 Divis Laboratories LtdEquity | 4.41% |
| Cohance Lifescience...Equity | 3.82% |
Aditya Birla SL Pharma & Healthcare Fund - Dir (G)
| Name | Assets |
|---|---|
